Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | OXTR | P30559 | 1/20 | 0.31 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.31 |
| ▸ | GRK2 | P25098 | 1/20 | 0.30 |
| ▸ | GRK5 | P34947 | 1/20 | 0.30 |
| ▸ | GRK1 | Q15835 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7989450 | 0.91 | ALDH1A1 (0.34) | POLBROCK2MAPTALDH1A1 | |
| SCHEMBL7975471 | 0.81 | ALDH1A1 (0.34) | LMNATDP1ALDH1A1OXTRAVPR1A | |
| SCHEMBL7980528 | 0.77 | PKM (0.33) | OXTRAVPR1A | |
| SCHEMBL4315205 | 0.77 | POLB (0.37) | POLBROCK2MAPTALDH1A1GRK2 | |
| SCHEMBL7980536 | 0.76 | PTGDR2 (0.35) | POLBOXTRAVPR1A | |
| SCHEMBL7982833 | 0.76 | PKM (0.33) | OXTRAVPR1A | |
| SCHEMBL7969219 | 0.75 | KMT2A (0.34) | POLBTDP1OXTRAVPR1A | |
| SCHEMBL7979470 | 0.75 | MAPK1 (0.36) | GRIN1GRIN2BALDH1A1 | |
| SCHEMBL7982224 | 0.73 | RAB9A (0.34) | ALDH1A1 | |
| SCHEMBL7979149 | 0.73 | NPC1 (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009133387-A1 | INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS | LECTUS THERAPEUTICS LIMITED (GB) | 2009-11-05 | — | — | WO | disclosed |